Vitamin D status of pediatric epilepsy patients and evaluation of affecting factors

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Anti-seizure medication that is used in patients with epilepsy is one of the significant risk factors associated with abnormal vitamin D status in these patients. We aimed to identify risk factors related to hypovitaminosis D in pediatric patients treated with anti-seizure medications. Method . A cross-sectional retrospective cohort study was conducted on 127 pediatric epilepsy patients who received anti-seizure drugs from December 2021 to December 2022. Demographic data, seizure types, diet, physical activity, duration, and types of anti-seizure medications were analyzed. Results ; Among the 127 patients in this study, 53% were male, and the mean age was 9,1 ± 4.6 years (range: 2–17). The mean serum 25(OH)D level at baseline in winter/autumn was 24.2 ± 14.2 ng/mL; 47.0% of the patients were 25(OH) D deficient, 23% 25(OH)D insufficient, and 30% had a vitamin D level within the normal range. Vitamin 25(OH) D level was 27,6 ± 12,2 in the epilepsy group with non-enzyme-induced anti-seizure drugs, 21,76 ± 19,7 in enzyme-induced anti-seizure drugs, and 13,96 ± 7,9 in the group with combined anti- seizures drugs (p  <  0.001). Conclusion : : The number of anti seizures drugs, treatment with enzyme-induced anti-seizure drugs, long duration of epilepsy, abnormal magnetic resonance imaging, and etiology play an important role on vitamine D level

Article activity feed